Measure
The test shows the current AA/EPA ratio.
html
The AA/EPA ratio turns the balance between omega-6 and omega-3 into a simple number to track. The target is below 3:1.
A lower ratio indicates a greater relative presence of EPA compared with arachidonic acid (AA). Measuring the baseline and repeating the test later makes it possible to see, in numbers, how much the fatty-acid profile changed.
The test shows the current AA/EPA ratio.
A simple target to guide the strategy and track progress.
The new measurement objectively shows the change achieved.
| Indicator | What it shows | Target |
|---|---|---|
| Omega-6:3 ratio | AA / EPA | Below 3:1 |
| Omega-3 Index WB | EPA + DHA in whole blood | 8% or more |
| Fluidity ratio | (PA + SA) / (EPA + DHA) | Below 4:1 |
The balance between omega-6 and omega-3 has been studied for decades. Work by Simopoulos helped establish the relevance of the ratio, and recent UK Biobank data reinforce the association between a higher plasma omega-6/omega-3 ratio and greater all-cause, cardiovascular and cancer mortality.
The ratio is one of the central themes of the site and should be read together with the Omega-3 Index. This combination helps provide a better understanding of chronic low-grade inflammation and the relationships observed in metabolism and cardiovascular health.
Below 3:1 for the AA/EPA ratio.
Because the second test shows whether the strategy increased EPA and moved the ratio closer to the target.
The overall picture becomes more useful when it is also tracked with the Omega-3 Index and the other fatty-acid profile indicators.
Open the material page to view the visual version, related references and the reviewed PDF for reading or sharing.
Continue from the article to reviewed presentations and return to the topic pages whenever you want to examine the evidence in more depth.